Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Sagimet Biosciences Inc.

CIK 1400118 SGMT·Pharmaceutical Preparations · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

Sagimet Biosciences Inc. cited accounting standard ASU 2016-13 for the first time in this filing series

The Company adopted ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments on January 1, 2024.
Evidence
Adopted
2016-13
Contexts
The Company adopted ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments on January 1, 2024.
New standards
2016-13
Prior filed
2025-03-12
Prior form
10-K
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.